Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: A multiple interaction analysis

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 336-342

  Liu, Li ^a   Wu, Chen ^b   Wang, Ying ^a   Zhong, Rong ^a   Wang, Feng ^a   Zhang, Xuemei ^c   Duan, Shengyu ^a   Lou, Jiao ^a   Yu, Dianke ^b   Tan, Wen ^b   Yuan, Jing ^a   Wu, Tangchun ^a   Nie, Shaofa ^a   Miao, Xiaoping ^a   Lin, Dongxin ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CANCER HOSPITAL   (China)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CHINESE; CLASSIFICATION AND REGRESSION TREE; CONTROLLED STUDY; FEMALE; GASTRIC CARDIA ADENOCARCINOMA; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING; STOMACH ADENOCARCINOMA;

EID: 79952307251     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq264     Document Type: Article

References (47)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. He,Y.T. et al. (2008) Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. Eur. J. Cancer Prev., 17, 71-76.
3. Crew,K.D. et al. (2006) Epidemiology of gastric cancer. World J. Gastroenterol., 12, 354-362.
4. Kelley,J.R. et al. (2003) Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol., 56, 1-9.
5. Wogan,G.N. et al. (2004) Environmental and chemical carcinogenesis. Semin. Cancer Biol., 14, 473-486.
6. Trafalis,D.T. et al. (2010) CYP2E1 and risk of chemically mediated cancers. Expert Opin. Drug Metab. Toxicol., 6, 307-319.
7. Dalhoff,K. et al. (2005) Cancer and molecular biomarkers of phase 2. Methods Enzymol., 400, 618-627.
8. Hecht,S.S. (2003) Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat. Rev. Cancer, 3, 733-744.
9. Egeblad,M. et al. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2, 161-174.
10. Kessenbrock,K. et al. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141, 52-67.
11. Miao,X. et al. (2004) Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma. Cancer Res., 64, 2680-2683.
12. Kotnis,A. et al. (2008) Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. Br. J. Cancer, 99, 1340-1347.
13. Qiu,L. et al. (2008) Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur. J. Cancer, 44, 2241-2253.
14. Miao,X. et al. (2006) Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology, 131, 420-427.
15. Hao,B. et al. (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res., 64, 4378-4384.
16. Dai,S. et al. (2009) P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies. Hum. Genet., 125, 633-638.
17. Zhou,R.M. et al. (2010) Polymorphisms in promoter region of FAS and FASL gene and risk of gastric cardiac adenocarcinoma. J. Gastroenterol. Hepatol., 25, 555-561.
18. Hahn,L.W. et al. (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics, 19, 376-382.
19. Hosmer,D.W. et al. (2000) Applied Logistic Regression.Wiley, New York, NY.
20. Garcia-Magarinos,M. et al. (2009) Evaluating the ability of tree-based methods and logistic regression for the detection of SNP-SNP interaction. Ann. Hum. Genet., 73, 360-369.
21. Wang,W. et al. (2007) Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin. Cancer Res., 13, 5974-5981.
22. Zhai,R. et al. (2010) Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma. J. Clin. Oncol., 28, 2445-2451.
23. Andrew,A.S. et al. (2008) DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum. Hered., 65, 105-118.
24. Wang,Y.G. et al. (2003) [Poly(AT) polymorphism in DNA repair gene XPC and lung cancer risk]. Zhonghua Zhong Liu Za Zhi, 25, 555-557.
25. Miao,X. et al. (2003) A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res., 63, 3987-3990.
26. Manicone,A.M. et al. (2008) Matrix metalloproteinases as modulators of inflammation. Semin. Cell Dev. Biol., 19, 34-41.
27. Yoon,S.O. et al. (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol., 36, 128-137.
28. Yokoyama,K. et al. (2003) Increased invasion and matrixmetalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int. J. Oncol., 22, 891-898.
29. Li,Y. et al. (2009) Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis. Esophagus, 22, 664-667.
30. Karadag,N. et al. (2008) Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis. Appl. Immunohistochem. Mol. Morphol., 16, 148-152.
31. Price,S.J. et al. (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J. Biol. Chem., 276, 7549-7558.
32. Bergers,G. et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2, 737-744.
33. Baruch,R.R. et al. (2001) Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation. Cell Biol. Int., 25, 411-420.
34. Nagar,S. et al. (2006) Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol. Pharmacol., 69, 2084-2092.
35. Au,W.W. et al. (2003) Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect., 111, 1843-1850.
36. Khan,S.G. et al. (2002) The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res., 30, 3624-3631.
37. Baptiste,N. et al. (2002) The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene, 21, 9-21.
38. Wu,J. et al. (2003) A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J. Immunol., 170, 132-138.
39. Yang,M. et al. (2008) Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin. Cancer Res., 14, 3230-3236.
40. Zhang,B. et al. (2007) Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis, 28, 1067-1073.
41. Zhang,X. et al. (2005) Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J. Med. Genet., 42, 479-484.
42. Wisniewski,P. et al. (2010) Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway. Cell. Signal., 22, 212-220.
43. Almendro,V. et al. (2009) The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin. PLoS One, 4, e4728.
44. Toh,Y. et al. (2010) Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int. J. Clin. Oncol., 15, 135-144.
45. Boccia,S. et al. (2005) Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study. Cancer Lett., 229, 235-243.
46. Guaderman,W. (2002) Sample size requirements for association studies of gene-gene interaction. Am. J. Epidemiol., 155, 478-484.
47. Ritchie,M. et al. (2003) Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeity. Genet. Epidemiol., 24, 150-157.